|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
fasudil results in decreased expression of ACTA2 mRNA |
CTD |
PMID:22465603 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
fasudil results in increased phosphorylation of and results in increased activity of AKT1 protein |
CTD |
PMID:17761835 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Arg1 |
arginase 1 |
increases expression |
EXP |
fasudil results in increased expression of ARG1 protein |
CTD |
PMID:30462329 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgef11 |
Rho guanine nucleotide exchange factor 11 |
decreases expression |
ISO |
fasudil results in decreased expression of ARHGEF11 mRNA; fasudil results in decreased expression of ARHGEF11 protein |
CTD |
PMID:26172442 |
|
NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:173,074,368...173,196,010
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
fasudil inhibits the reaction [Paraquat results in increased expression of BAX mRNA]; fasudil inhibits the reaction [Streptozocin results in increased expression of BAX protein] |
CTD |
PMID:22429817 PMID:30088170 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
EXP |
fasudil inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA]; fasudil inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] fasudil results in increased expression of BCL2 protein |
CTD |
PMID:17761835 PMID:22429817 PMID:30088170 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP protein]; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP protein |
CTD |
PMID:31935364 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
fasudil inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP3 protein]; fasudil inhibits the reaction [Paraquat results in increased expression of CASP3 mRNA] |
CTD |
PMID:17761835 PMID:30088170 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
fasudil inhibits the reaction [Acetaminophen results in increased expression of CCL2 protein] |
CTD |
PMID:34078832 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
EXP |
fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] |
CTD |
PMID:20037814 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cfl1 |
cofilin 1 |
decreases expression multiple interactions |
ISO EXP |
fasudil results in decreased expression of CFL1 mRNA fasudil inhibits the reaction [Streptozocin results in increased phosphorylation of CFL1 protein] fasudil results in decreased expression of and results in decreased phosphorylation of CFL1 protein |
CTD |
PMID:22062134 PMID:26172442 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression multiple interactions |
ISO |
fasudil results in decreased expression of COL1A1 mRNA 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of COL1A1 mRNA]; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of COL1A1 mRNA |
CTD |
PMID:22465603 PMID:31935364 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
fasudil results in decreased expression of COL3A1 mRNA |
CTD |
PMID:22465603 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
fasudil inhibits the reaction [Streptozocin results in increased expression of FN1 protein] |
CTD |
PMID:23376009 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gap43 |
growth associated protein 43 |
multiple interactions |
EXP |
[fasudil co-treated with Methylmercury Compounds] results in increased expression of and results in increased phosphorylation of GAP43 protein |
CTD |
PMID:30462329 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
fasudil inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] |
CTD |
PMID:30831131 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression |
ISO |
fasudil affects the expression of HMOX1 protein |
CTD |
PMID:26120273 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
fasudil inhibits the reaction [Streptozocin results in increased expression of ICAM1 protein] |
CTD |
PMID:23376009 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il10 |
interleukin 10 |
increases expression |
EXP |
fasudil results in increased expression of IL10 protein |
CTD |
PMID:30462329 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
EXP |
fasudil inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA] |
CTD |
PMID:18660453 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
fasudil inhibits the reaction [Methylmercury Compounds results in increased expression of IL1B protein]; fasudil inhibits the reaction [Paraquat results in increased expression of IL1B protein] fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein]; fasudil inhibits the reaction [Paraquat results in increased secretion of IL1B protein] fasudil inhibits the reaction [Acetaminophen results in increased expression of IL1B protein]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein] |
CTD |
PMID:30088170 PMID:30462329 PMID:30924981 PMID:34078832 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP ISO |
fasudil inhibits the reaction [Methylmercury Compounds results in increased expression of IL6 protein]; fasudil inhibits the reaction [Paraquat results in increased expression of IL6 protein] fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]; fasudil inhibits the reaction [Paraquat results in increased secretion of IL6 protein] fasudil inhibits the reaction [Acetaminophen results in increased expression of IL6 protein]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein] |
CTD |
PMID:30088170 PMID:30462329 PMID:30924981 PMID:34078832 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Limk2 |
LIM domain kinase 2 |
multiple interactions |
EXP |
fasudil inhibits the reaction [Streptozocin results in increased phosphorylation of LIMK2 protein] |
CTD |
PMID:22062134 |
|
NCBI chr14:78,208,182...78,286,106
Ensembl chr14:78,218,063...78,286,007
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
decreases expression |
ISO |
fasudil results in decreased expression of MAP3K7 protein |
CTD |
PMID:22465603 |
|
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
EXP |
fasudil inhibits the reaction [methylmercuric chloride results in decreased expression of MAPT protein] |
CTD |
PMID:20869980 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mmp8 |
matrix metallopeptidase 8 |
affects expression |
ISO |
fasudil affects the expression of MMP8 mRNA |
CTD |
PMID:26120273 |
|
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
affects expression |
ISO |
fasudil affects the expression of MMP9 mRNA |
CTD |
PMID:26120273 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of MPO protein] |
CTD |
PMID:30924981 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myh7 |
myosin heavy chain 7 |
decreases expression |
ISO |
fasudil results in decreased expression of MYH7 mRNA |
CTD |
PMID:22465603 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Myl1 |
myosin, light chain 1 |
multiple interactions |
EXP |
fasudil inhibits the reaction [Norepinephrine results in increased phosphorylation of MYL1 protein] |
CTD |
PMID:37963515 |
|
NCBI chr 9:68,437,514...68,458,256
Ensembl chr 9:68,437,517...68,458,261
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP ISO |
fasudil inhibits the reaction [Streptozocin results in decreased expression of NFKBIA protein] fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:23376009 PMID:30924981 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
fasudil inhibits the reaction [Methylmercury Compounds results in increased expression of NOS2 protein] |
CTD |
PMID:30462329 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
multiple interactions |
EXP |
fasudil inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 protein] |
CTD |
PMID:16452496 |
|
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
G |
Nppa |
natriuretic peptide A |
decreases expression |
ISO |
fasudil results in decreased expression of NPPA mRNA |
CTD |
PMID:22465603 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
decreases expression |
ISO |
fasudil results in decreased expression of NPPB mRNA |
CTD |
PMID:22465603 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Pkn2 |
protein kinase N2 |
decreases activity |
ISO |
fasudil results in decreased activity of PKN2 protein |
CTD |
PMID:10998351 |
|
NCBI chr 2:231,793,584...231,898,953
Ensembl chr 2:231,793,584...231,898,953
|
|
G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
multiple interactions |
EXP |
fasudil inhibits the reaction [Norepinephrine results in increased phosphorylation of PPP1R12A protein]; fasudil inhibits the reaction [Paraquat results in increased phosphorylation of PPP1R12A protein]; fasudil inhibits the reaction [Streptozocin results in increased expression of PPP1R12A protein modified form] |
CTD |
PMID:22429817 PMID:30088170 PMID:37963515 |
|
NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
fasudil inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of RELA protein]; fasudil inhibits the reaction [Streptozocin results in increased expression of and affects the localization of RELA protein] fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of RELA protein] |
CTD |
PMID:23376009 PMID:30462329 PMID:30924981 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rho |
rhodopsin |
multiple interactions |
ISO EXP |
fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of RHO mRNA]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of RHO protein] fasudil inhibits the reaction [Paraquat results in increased expression of RHO protein] fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of RHO mRNA]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of RHO protein]; fasudil inhibits the reaction [Paraquat results in increased expression of RHO protein] |
CTD |
PMID:30088170 PMID:30924981 |
|
NCBI chr 4:148,975,597...148,988,693
Ensembl chr 4:148,980,611...148,985,773
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression multiple interactions |
ISO |
fasudil results in decreased expression of RHOA mRNA; fasudil results in decreased expression of RHOA protein fasudil inhibits the reaction [Acetaminophen results in increased expression of RHOA protein] |
CTD |
PMID:26172442 PMID:34078832 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
decreases expression multiple interactions |
ISO EXP |
fasudil results in decreased expression of ROCK1 mRNA; fasudil results in decreased expression of ROCK1 protein fasudil inhibits the reaction [Acetaminophen results in increased expression of ROCK1 protein]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK1 mRNA]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK1 protein] fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK1 mRNA]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK1 protein]; fasudil inhibits the reaction [Paraquat results in increased expression of ROCK1 protein] fasudil affects the reaction [Daunorubicin affects the expression of ROCK1 mRNA]; fasudil inhibits the reaction [Paraquat results in increased expression of ROCK1 protein]; fasudil inhibits the reaction [Streptozocin results in increased activity of ROCK1 protein]; fasudil inhibits the reaction [Streptozocin results in increased expression of ROCK1 mRNA] |
CTD |
PMID:20037814 PMID:22429817 PMID:23376009 PMID:26172442 PMID:30088170 PMID:30924981 PMID:34078832 More...
|
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
decreases activity multiple interactions |
EXP ISO |
fasudil results in decreased activity of ROCK2 protein fasudil inhibits the reaction [Acetaminophen results in increased expression of ROCK2 protein]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK2 mRNA]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK2 protein] |
CTD |
PMID:10998351 PMID:30924981 PMID:34078832 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
decreases activity |
ISO |
fasudil results in decreased activity of RPS6KA1 protein |
CTD |
PMID:10998351 |
|
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
|
|
G |
Rps6ka5 |
ribosomal protein S6 kinase A5 |
decreases activity |
ISO |
fasudil results in decreased activity of RPS6KA5 protein |
CTD |
PMID:10998351 |
|
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases activity |
ISO |
fasudil results in decreased activity of RPS6KB1 protein |
CTD |
PMID:10998351 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of RUNX2 mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of RUNX2 protein]; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of RUNX2 mRNA; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of RUNX2 protein |
CTD |
PMID:31935364 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Slc12a2 |
solute carrier family 12 member 2 |
increases expression |
ISO |
fasudil results in increased expression of SLC12A2 protein |
CTD |
PMID:21474433 |
|
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
EXP |
fasudil inhibits the reaction [propionic acid results in increased expression of SNCA mRNA] |
CTD |
PMID:32481507 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Syp |
synaptophysin |
multiple interactions |
EXP |
fasudil inhibits the reaction [Rotenone results in decreased expression of SYP mRNA]; fasudil inhibits the reaction [Streptozocin results in decreased expression of SYP mRNA]; fasudil inhibits the reaction [Streptozocin results in decreased expression of SYP protein] |
CTD |
PMID:22062134 PMID:32481507 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression multiple interactions |
ISO EXP |
fasudil results in decreased expression of TGFB1 protein fasudil inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein] |
CTD |
PMID:22465603 PMID:23376009 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
[[propionic acid co-treated with fasudil] affects the susceptibility to Rotenone] which results in increased expression of TH mRNA |
CTD |
PMID:32481507 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
affects expression |
ISO |
fasudil affects the expression of TIMP1 mRNA |
CTD |
PMID:22465603 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
EXP ISO |
fasudil inhibits the reaction [Paraquat results in decreased expression of TJP1 protein] |
CTD |
PMID:30088170 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tnf |
tumor necrosis factor |
affects expression multiple interactions |
ISO EXP |
fasudil affects the expression of TNF mRNA fasudil inhibits the reaction [Acetaminophen results in increased expression of TNF protein]; fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein] fasudil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]; fasudil inhibits the reaction [Paraquat results in increased secretion of TNF protein] fasudil inhibits the reaction [Methylmercury Compounds results in increased expression of TNF protein]; fasudil inhibits the reaction [Paraquat results in increased expression of TNF protein] |
CTD |
PMID:26120273 PMID:30088170 PMID:30462329 PMID:30924981 PMID:34078832 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
multiple interactions |
ISO |
fasudil inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 protein] |
CTD |
PMID:30831131 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
ISO |
fasudil inhibits the reaction [Oxygen deficiency results in increased expression of TRPC6 protein] |
CTD |
PMID:30831131 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Vegfa |
vascular endothelial growth factor A |
affects expression |
ISO |
fasudil affects the expression of VEGFA mRNA |
CTD |
PMID:26120273 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression affects localization |
EXP ISO |
ML 7 results in decreased expression of ACTA2 ML 7 affects the localization of ACTA2 protein |
CTD |
PMID:11591817 PMID:11868461 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
ML 7 results in decreased susceptibility to [quinocetone results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:26446980 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased expression of BAX protein; ML 7 results in increased susceptibility to [quinocetone results in increased expression of BAX protein] |
CTD |
PMID:26446980 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
decreases phosphorylation |
ISO |
ML 7 results in decreased phosphorylation of BCAR1 protein |
CTD |
PMID:18718759 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in decreased expression of BCL2 protein; ML 7 results in increased susceptibility to [quinocetone results in decreased expression of BCL2 protein] |
CTD |
PMID:26446980 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
ML 7 results in decreased expression of BIRC5 protein |
CTD |
PMID:18710790 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased cleavage of CASP3 protein; [ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein; FADD protein affects the reaction [[ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein] |
CTD |
PMID:16723733 PMID:26446980 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased cleavage of CASP8 protein; ML 7 results in increased susceptibility to [quinocetone results in increased cleavage of CASP8 protein] |
CTD |
PMID:26446980 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased cleavage of CASP9 protein; ML 7 results in increased susceptibility to [quinocetone results in increased cleavage of CASP9 protein] |
CTD |
PMID:26446980 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of CCNA2 protein] |
CTD |
PMID:16799973 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
EXP ISO |
ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 mRNA]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 protein] ML 7 results in decreased expression of CCND1 protein |
CTD |
PMID:16799973 PMID:18710790 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of CCNE1 protein] |
CTD |
PMID:16799973 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdh1 |
cadherin 1 |
decreases activity affects localization |
ISO |
ML 7 results in decreased activity of CDH1 protein ML 7 affects the localization of CDH1 protein |
CTD |
PMID:16030252 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of CDK1 protein] |
CTD |
PMID:16799973 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
ML 7 results in decreased expression of CDKN1A protein |
CTD |
PMID:15252113 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
ML 7 results in increased expression of CDKN1B protein |
CTD |
PMID:15252113 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
affects localization |
ISO |
ML 7 affects the localization of COL17A1 protein |
CTD |
PMID:14691950 |
|
NCBI chr 1:246,530,589...246,577,559
Ensembl chr 1:246,531,367...246,577,632
|
|
G |
Csf2 |
colony stimulating factor 2 |
affects activity |
ISO |
ML 7 affects the activity of CSF2 protein |
CTD |
PMID:8471626 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctnnb1 |
catenin beta 1 |
affects localization decreases expression |
ISO |
ML 7 affects the localization of CTNNB1 protein ML 7 results in decreased expression of CTNNB1 protein |
CTD |
PMID:18710790 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions |
ISO |
ML 7 inhibits the reaction [CXCL12 protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:11751986 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Dst |
dystonin |
affects localization |
ISO |
ML 7 affects the localization of DST protein |
CTD |
PMID:14691950 |
|
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein affects the localization of MYL9 protein modified form]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCNA2 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 mRNA]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCNE1 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of CDK1 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of FOS protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of JUN protein]; ML 7 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:16799973 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions decreases activity affects activity |
ISO EXP |
ML 7 inhibits the reaction [F2 protein results in increased phosphorylation of MYL9 protein] [ML 7 results in decreased activity of MYLK protein] which results in decreased activity of F2 protein ML 7 affects the activity of F2 protein |
CTD |
PMID:1643115 PMID:14557824 PMID:15284075 PMID:16675616 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fadd |
Fas associated via death domain |
multiple interactions |
ISO |
FADD protein affects the reaction [[ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein] |
CTD |
PMID:16723733 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of FOS protein] |
CTD |
PMID:16799973 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
ML 7 inhibits the reaction [Ionomycin results in increased secretion of HEXB protein] |
CTD |
PMID:14499669 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
ML 7 inhibits the reaction [IL17A protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:19940258 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Itga3 |
integrin subunit alpha 3 |
multiple interactions |
ISO |
ML 7 affects the localization of [ITGA3 protein binds to ITGB1 protein] |
CTD |
PMID:14691950 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Itga6 |
integrin subunit alpha 6 |
multiple interactions |
ISO |
ML 7 affects the localization of [ITGA6 protein binds to ITGB4 protein] |
CTD |
PMID:14691950 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
ML 7 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAM protein] |
CTD |
PMID:19374788 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb1 |
integrin subunit beta 1 |
multiple interactions decreases activity |
ISO |
ML 7 affects the localization of [ITGA3 protein binds to ITGB1 protein] ML 7 results in decreased activity of ITGB1 protein |
CTD |
PMID:14691950 PMID:16723733 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itgb4 |
integrin subunit beta 4 |
multiple interactions |
ISO |
ML 7 affects the localization of [ITGA6 protein binds to ITGB4 protein] |
CTD |
PMID:14691950 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of JUN protein] |
CTD |
PMID:16799973 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lama3 |
laminin subunit alpha 3 |
affects localization |
ISO |
ML 7 affects the localization of LAMA3 protein |
CTD |
PMID:14691950 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
ML 7 results in decreased phosphorylation of MAPK1 protein [ML 7 co-treated with quinocetone] results in increased phosphorylation of MAPK1 protein; ML 7 results in increased susceptibility to [quinocetone results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:18710790 PMID:26446980 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased phosphorylation of MAPK14 protein; ML 7 results in increased susceptibility to [quinocetone results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:26446980 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
ML 7 results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:18710790 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:26446980 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions decreases activity |
EXP ISO |
ML 7 inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein] ML 7 results in decreased activity of MPO protein |
CTD |
PMID:15863634 PMID:19374788 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
ML 7 results in decreased expression of MYC protein |
CTD |
PMID:18710790 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh2 |
myosin heavy chain 2 |
affects localization decreases activity |
ISO |
ML 7 affects the localization of MYH2 protein ML 7 results in decreased activity of MYH2 protein |
CTD |
PMID:16030252 |
|
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
|
|
G |
Myl7 |
myosin light chain 7 |
multiple interactions decreases phosphorylation |
ISO |
ML 7 inhibits the reaction [Phenylephrine results in increased phosphorylation of MYL7 protein] ML 7 results in decreased phosphorylation of MYL7 protein |
CTD |
PMID:15621049 |
|
NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244
|
|
G |
Myl9 |
myosin light chain 9 |
multiple interactions decreases expression decreases phosphorylation |
ISO EXP |
[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein; ML 7 inhibits the reaction [CXCL12 protein results in increased phosphorylation of MYL9 protein]; ML 7 inhibits the reaction [F2 protein results in increased phosphorylation of MYL9 protein]; ML 7 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MYL9 protein] ML 7 results in decreased expression of MYL9 protein modified form ML 7 results in decreased phosphorylation of MYL9 protein [[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein] which results in increased secretion of REN protein; [ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein; ML 7 inhibits the reaction [Deamino Arginine Vasopressin results in increased phosphorylation of MYL9 protein]; ML 7 inhibits the reaction [EGF protein affects the localization of MYL9 protein modified form]; ML 7 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MYL9 protein] ML 7 inhibits the reaction [IL17A protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:1643115 PMID:7503253 PMID:9618396 PMID:11751986 PMID:12745062 PMID:15284075 PMID:15347643 PMID:15863634 PMID:16799973 PMID:17138966 PMID:17272349 PMID:17914957 PMID:18710790 PMID:18835913 PMID:19525378 PMID:19940258 PMID:19943851 More...
|
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Mylk |
myosin light chain kinase |
multiple interactions decreases activity |
ISO EXP |
[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein; [ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein; FADD protein affects the reaction [[ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein]; ML 7 inhibits the reaction [Calcium deficiency results in increased activity of MYLK protein]; ML 7 inhibits the reaction [Ethanol results in increased activity of MYLK protein] [ML 7 results in decreased activity of MYLK protein] which results in decreased activity of F2 protein; ML 7 results in decreased activity of MYLK protein ML 7 inhibits the reaction [Lipopolysaccharides results in increased expression of MYLK mRNA]; ML 7 inhibits the reaction [Lipopolysaccharides results in increased expression of MYLK protein]; ML 7 inhibits the reaction [MYLK protein results in increased uptake of Glucose] [[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein] which results in increased secretion of REN protein; [ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein |
CTD |
PMID:1643115 PMID:9618396 PMID:10198341 PMID:10733514 PMID:11054866 PMID:12534346 PMID:16675616 PMID:16723733 PMID:17541957 PMID:18773891 PMID:18835913 PMID:19374788 PMID:19943851 More...
|
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Myod1 |
myogenic differentiation 1 |
decreases expression |
ISO |
ML 7 results in decreased expression of MYOD1 protein |
CTD |
PMID:15252113 |
|
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
|
|
G |
Myog |
myogenin |
decreases expression |
ISO |
ML 7 results in decreased expression of MYOG protein |
CTD |
PMID:15252113 |
|
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
ML 7 inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NCF1 protein]; ML 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of NCF1 protein] |
CTD |
PMID:7575484 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Prkcb |
protein kinase C, beta |
decreases expression |
EXP |
ML 7 results in decreased expression of PRKCB protein |
CTD |
PMID:17272349 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
ISO |
ML 7 results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:18718759 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Rac1 |
Rac family small GTPase 1 |
decreases activity increases activity |
EXP |
ML 7 results in decreased activity of RAC1 protein ML 7 results in increased activity of RAC1 protein |
CTD |
PMID:12105187 PMID:12745062 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Ren |
renin |
multiple interactions increases secretion |
EXP |
[[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein] which results in increased secretion of REN protein; calyculin A inhibits the reaction [ML 7 results in increased secretion of REN protein]; ML 7 inhibits the reaction [Calcium results in decreased secretion of REN protein] |
CTD |
PMID:9618396 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rps6ka5 |
ribosomal protein S6 kinase A5 |
decreases activity |
ISO |
ML 7 results in decreased activity of RPS6KA5 protein |
CTD |
PMID:12534346 |
|
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP ISO |
ML 7 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] ML 7 results in decreased susceptibility to [quinocetone results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:16799973 PMID:26446980 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions decreases activity decreases expression |
EXP |
ML 7 inhibits the reaction [SLC2A2 protein results in increased uptake of Glucose] ML 7 results in decreased activity of SLC2A2 protein ML 7 results in decreased expression of SLC2A2 protein |
CTD |
PMID:17272349 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
ISO |
ML 7 inhibits the reaction [Oxygen deficiency affects the localization of TJP1 protein] ML 7 inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]] |
CTD |
PMID:20164382 PMID:33675858 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
decreases activity |
ISO |
ML 7 results in decreased activity of TRPC6 protein |
CTD |
PMID:17603544 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
increases activity |
ISO |
ML 7 results in increased activity of TRPC7 protein |
CTD |
PMID:17603544 |
|
NCBI chr17:7,708,911...7,833,435
Ensembl chr17:7,709,583...7,833,435
|
|